Previous 10 | Next 10 |
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Hyperfine, Inc. 2022 Q3 - Results - Earnings Call Presentation
Hyperfine ( NASDAQ: HYPR ) stock rose ~6% on Friday after Q3 results beat estimates. Net loss narrowed to -$13.17M, compared to -$16.39M in Q3 2021. Q3 revenues grew +532.88% Y/Y to ~$2.35M. Device revenue grew +872.5% Y/Y to ~$1.95M, while Service re...
Hyperfine press release ( NASDAQ: HYPR ): Q3 GAAP EPS of -$0.19 beats by $0.07 . Revenue of $2.35M (+535.1% Y/Y) beats by $0.8M . For further details see: Hyperfine GAAP EPS of -$0.19 beats by $0.07, revenue of $2.35M beats by $0.8M
GUILFORD, CONNECTICUT, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended September 30, 2022 and provided a business update. Managemen...
GUILFORD, Conn., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the third quarter 2022 on Thursday, November 10, 2022. Comp...
Hyperfine ( NASDAQ: HYPR ) has named medical device industry veteran Maria Sainz as President and CEO of Hyperfine, effective Oct. 24, 2022. Scott Huennekens, who currently serves as interim President and CEO, will stay on as Executive Chairperson of the Board. HYPR ...
GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (“Hyperfine” or “the Company”), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that ...
SAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennek...
GUILFORD, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that management will present at two upcoming conferences: Scott Huennekens, Interim President and Chief...
Wells Fargo has downgraded Hyperfine ( NASDAQ: HYPR ) to equal weight from overweight following disappointing Q2 2022 results Wednesday that included lowering guidance . The firm also cut its price target to $2.40 from $8 (~29% upside based on Wednesday's close). T...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...